Status:
COMPLETED
Estimation of Kidney Function Through Combination of Renal Biomarkers in Blood and Urine of Healthy Infants and Children.
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Renal Biomarkers in Children
Eligibility:
All Genders
Up to 12 years
Brief Summary
To characterize the relationship of renal biomarkers (Creatinine, albumin, Cystatin C, NGAL, beta-trace protein, beta-2 microglobulin, and uromodulin) between each other and the variation over age, me...
Detailed Description
Despite relevant research in renal biomarkers, there is currently no optimal marker available that reliably quantifies kidney function and indicates kidney injury in its early stages. The combination ...
Eligibility Criteria
Inclusion
- healthy patients for elective surgery, requiring venous access via peripheral venous canula
Exclusion
- chronic kidney disease
- acute kidney failure (stage 2 or above as defined by Kidney Disease Improving Global Outcomes (KDIGO) consensus 2012))
- sepsis
- shock
- major haemorrhage
- second or third degree burns
- liver failure
- chronic diseases with effecting the kidney (systemic lupus erythematosus, amyloidosis)
Key Trial Info
Start Date :
December 17 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 5 2020
Estimated Enrollment :
158 Patients enrolled
Trial Details
Trial ID
NCT03751397
Start Date
December 17 2018
End Date
June 5 2020
Last Update
July 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Basel Children's Hospital
Basel, Switzerland, 4031